Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J. Duncavage, Matthew J. Walter, Kevin Elliott et al.|New England Journal of Medicine|2018Cited by 121
Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphomaReid W. Merryman, Eric D. Jacobsen, Natasha Edwin et al.|Blood Advances|2020Cited by 58
Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Phase 2 Clinical Trials and Off-Trial ExperienceReid W. Merryman, Eric D. Jacobsen, Brad S. Kahl et al.|Blood|2018Cited by 7